SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 26 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,982 | -40.9% | 25,774 | 0.0% | 0.00% | – |
| Q1 2024 | $27,063 | +51.7% | 25,774 | 0.0% | 0.00% | – |
| Q4 2023 | $17,836 | -7.7% | 25,774 | 0.0% | 0.00% | – |
| Q3 2023 | $19,333 | -34.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2023 | $29,382 | -24.0% | 25,774 | 0.0% | 0.00% | – |
| Q1 2023 | $38,661 | -49.7% | 25,774 | -50.0% | 0.00% | – |
| Q4 2022 | $76,806 | +92.0% | 51,548 | +100.0% | 0.00% | – |
| Q3 2022 | $40,000 | -32.2% | 25,774 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -88.7% | 25,774 | -88.6% | 0.00% | – |
| Q1 2022 | $521,000 | -57.3% | 225,572 | +7.3% | 0.00% | – |
| Q4 2021 | $1,220,000 | -31.0% | 210,292 | +25.2% | 0.00% | – |
| Q3 2021 | $1,768,000 | +81.1% | 168,031 | +68.0% | 0.00% | – |
| Q2 2021 | $976,000 | +14.3% | 100,000 | +70.2% | 0.00% | – |
| Q1 2021 | $854,000 | – | 58,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 650,000 | $403,065 | 0.07% |
| Deuterium Capital Management, LLC | 11,000 | $6,821 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 172,835 | $107,175 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77,900 | $48,306 | 0.00% |
| XTX Topco Ltd | 14,047 | $8,711 | 0.00% |
| Leo Wealth, LLC | 14,845 | $9,205 | 0.00% |
| NORTHERN TRUST CORP | 25,983 | $16,112 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Cresset Asset Management, LLC | 19,671 | $12,198 | 0.00% |
| Banque Cantonale Vaudoise | 3,900 | $2 | 0.00% |